Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Family Medicine
 Disease Category: Metastatic Cancer
Location: United States, ND

Trial Information

A research study for patients with metastatic pancreatic cancer. You may qualify for this study if you have a diagnosis of an advanced type of pancreatic cancer for which standard therapy is not optimal.

A research study of an investigational drug for patients with metastatic pancreatic cancer. The study is trying to determine if the Investigational Drug combined with gemcitabine results in a better outcome for patients than treatment with gemcitabine alone. Gemcitabine is approved by the United States Food and Drug Administration for the treatment of metastatic pancreatic cancer.

Patient Inclusion Criteria: Adult patients who have been diagnosed with metastatic pancreatic cancer who have not received prior chemotherapy for treatment

Patient Exclusion Criteria: Patients who have received prior chemotherapy treatment

Joan Galbraith, Pharmacy Quality and Clinical Research Manager
St. Alexius Medical Center
931 South 9th Street
Suite 201
Bismarck, ND 58504
Phone: (701) 530-6954
Fax: (701) 530-6970
Email: jgalbraith@primecare.org

View Map

Research Center Information: St. Alexius Medical Center

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.